To access this element change to forms mode OFF
Grant Award View - GA204228
Defining the impact of chronic lung disease on COVID-19 and developing...
GA ID:
GA204228
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
3-Nov-2021
Publish Date:
6-Dec-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 1-Jan-2025
Value (AUD):
$896,784.20
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
Defining the impact of chronic lung disease on COVID-19 and developing effective therapies
Purpose:
COVID-19 disease is driven by virus-induced, hyper-inflammation that damages the lungs. Patients with chronic lung disease, such as chronic obstructive pulmonary disease (COPD) and tuberculosis (TB), have increased severity of COVID-19 disease. Using our models of TB and smoking-induced COPD, we will define how chronic lung disease increases the severity of COVID-19, how CoV2 infection exacerbates TB and COPD, and identify effective drugs that suppress this inflammatory damage to the lung.
GO ID:
GO Title:
2021 Ideas Grants
Internal Reference ID:
2021/GNT2011467
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Sydney
Recipient ABN:
15 211 513 464
Grant Recipient Location
Suburb:
Camperdown
Town/City:
Camperdown
Postcode:
2050
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, NSW
Postcode:
Multiple
Country:
AUSTRALIA